A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. - Wikidata - wikimedia - TriplyDB

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

http://www.wikidata.org/entity/Q34575053

about

A nonimmunosuppressant approach on Asia psoriasis subjects: 5-year followup and 11-year data analysis Recent Insights Into the Genetics of Inflammatory Bowel Disease Wnt5a exhibits layer-specific expression in adult skin, is upregulated in psoriasis, and synergizes with type 1 interferon The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo The biological functions of T helper 17 cell effector cytokines in inflammation IL-17RC: a partner in IL-17 signaling and beyond Ustekinumab Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways Ustekinumab for the treatment of Crohn's disease: can it find its niche?β-catenin/TCF-1 pathway in T cell development and differentiation Profile of ustekinumab and its potential in patients with moderate-to-severe Crohn's disease.Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy Polymer-conjugated inhibitors of tumor necrosis factor-α for local control of inflammation Granuloma formation in pulmonary sarcoidosis Hydrogen/deuterium exchange mass spectrometry applied to IL-23 interaction characteristics: potential impact for therapeutics Interleukin-23: as a drug target for autoimmune inflammatory diseases Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy New targets in psoriatic arthritis Novel insights into the role of immune cells in skin and inducible skin-associated lymphoid tissue (iSALT)Induction of intestinal Th17 cells by segmented filamentous bacteria Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk Inflammatory bowel disease Development, cytokine profile and function of human interleukin 17-producing helper T cells Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants The synovio-entheseal complex in enthesoarthritis.IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease Genome-wide association scan in psoriasis: new insights into chronic inflammatory disease.Biologics in dermatologic therapy - an update.Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials.Genetic-based prediction of disease traits: prediction is very difficult, especially about the future Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: a meta-analysis.Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models.Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis.Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice.

P2860

Q21296668-2938EF09-9D07-4EB5-AFB0-5261805E1F00 Q22250935-E3D8BD03-B5D0-4B11-A24B-4A6541BE2345 Q24319773-0EC6BFCC-CEB4-4621-B769-854CC1A1C110 Q24600773-60B69685-7E1E-4EFF-ABC2-8EF321CA0E70 Q24614431-1A8B0217-1AA7-4B50-8FF0-819715CD147F Q24629783-1938C088-3A1F-45E2-82B9-68EBDCC65704 Q24651927-D655222D-329D-4D1C-B049-09B986809DF9 Q24653432-002FE2A0-3EC7-41E7-992E-5910AC337B4C Q26771890-BD769A94-1D38-4E6F-8944-21ABF64E71A0 Q26821842-DD5F0EF6-2CE3-4205-8D7F-4ECEF3EAC47D Q26825174-C1AFF489-6BDD-4717-A7C2-1C0D5524BAE5 Q26827714-607E3EC3-E45D-44ED-90D4-7245DED2F334 Q26852346-5813318B-9EA6-4FFA-ACC6-6720755F57A0 Q26863703-1DE21AB5-7713-405F-A040-030E352B1BB9 Q27004640-08C0E100-E80B-4201-85A3-DFF821F6E147 Q27009502-BB7494DC-21BB-418E-B582-C8D3818B1E0C Q27010562-CB5FEEEE-D94F-4260-BE02-9A6DCF26B67F Q28069592-7FB6B266-C4A6-4416-BA63-CDED30D85FBE Q28081241-CDA3F600-39DF-40AD-A33A-2A62FC8F85BC Q28131638-1FB1C75C-B2DF-4BB9-A305-8BC12B9BD8C3 Q28238414-C8A4A3AF-E61D-4A51-9418-413C6CDCA3EC Q28268370-875B6D17-CC3A-49D6-ACE0-EDF47BBDE777 Q28280687-3FC82279-A2AA-48DF-BBF2-9DAAE8B4A7A2 Q28482161-0282961B-A786-4D1B-93F7-A12C697B16C2 Q28587108-3A1CFF34-2C00-459C-BA73-2F87DF998C90 Q29616286-4654F7B3-BAF5-48B9-B96A-60FB642C5E9F Q29617131-54362DFF-36F8-43BE-A901-E958214AF3D7 Q30620977-332D5FAB-FABB-4BC2-AFA3-3A490F4AC442 Q31151707-A829B7D5-98B3-4A26-9EAD-5153F7ED037A Q33296981-2400EDF8-625F-437C-A330-D32BB4B6D374 Q33360030-9E915DFB-08F5-4D78-B612-D0396E95A781 Q33403660-9DC94405-CB22-4A03-9543-BDEA87275B37 Q33579359-3EE59DB8-4486-4218-B231-579951A8DDCB Q33607620-23E52DD5-371F-4C00-B7C5-EF655D5A0571 Q33625546-0BA6BAAC-468B-48AE-9BD6-764AF36D4670 Q33693846-FB056E7F-F30F-425F-B8E3-4306E6781D80 Q33710915-47F2B170-4EC6-4440-B843-7FCD00546453 Q33725862-19D99642-494D-4026-9EA8-B997248A056A Q33760897-9B6F5E71-9AA9-4549-8665-FD5DF88DA11C Q33761544-762DD57B-BE34-4748-8766-34E046846660

P2860

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

http://www.wikidata.org/entity/Q34575053

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

@ast

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

@en

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

@nl

type

label

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

@ast

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

@en

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

@nl

prefLabel

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

@ast

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

@en

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

@nl

P1433

Q34575053-D9AEA74F-C267-44FC-9EAA-D9C1651D180F

P1476

Q34575053-770FA09B-48F0-4F48-B647-DF959DA282A1

P2093

Q34575053-149CCEC8-C07A-4737-9111-F0E2432E3FD3

Q34575053-1AE32781-07F4-4B49-ACCF-2FC8EA1E649E

Q34575053-36AA1319-B7ED-4F84-A9F3-9653D410DF6D

Q34575053-4DB9ADFE-A073-4482-B313-EE7248C9AD85

Q34575053-8095A335-3369-4053-8F85-37974041FECD

Q34575053-86A7ED16-FF94-4D29-9888-896BF0E5A367

Q34575053-A9A01B61-BED7-48F5-AC23-861B2DFD9284

Q34575053-B7712A8A-A688-4B41-87BB-0772978FB808

Q34575053-D7EDD13B-FCC7-4B22-832E-726908CC9048

P304

Q34575053-A540BF65-C1A0-49BA-9C2B-239F265ADE86

P31

Q34575053-FD366D24-4674-44BB-9432-3C85D358CFB6

P356

Q34575053-29A1A2CD-7691-4F48-BD6E-557A457DCA17

P407

Q34575053-0158B5BA-A1F6-4FBB-A752-DEEB04959BC3

P433

Q34575053-7F8909DC-1F2E-40B9-86F4-4B183F5B0EED

P478

Q34575053-06F748CA-A0AF-46D9-AF73-743BB440B0B2

P577

Q34575053-23E6AD8A-9EF3-4ED8-BBD8-FD4846BF1F7A

P5875

Q34575053-DC71CD19-2A58-40C1-974B-124E651259A6

P698

Q34575053-F7F2F0D7-EED1-4BBC-92CD-A998F54356B2

P921

Q34575053-2349b479-d9d2-457c-81db-4f702fad12a5

Q34575053-D9092EF0-B3CC-48C6-9B8D-91723C339CDA

P356

P1433

The New England Journal of Medicine

P1476

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

@en

P2093

CNTO 1275 Psoriasis Study Group

http://www.w3.org/2001/XMLSchema#string

Craig Leonardi

http://www.w3.org/2001/XMLSchema#string

Cynthia Guzzo

http://www.w3.org/2001/XMLSchema#string

Gerald G Krueger

http://www.w3.org/2001/XMLSchema#string

Lisa T Dooley

http://www.w3.org/2001/XMLSchema#string

Mark Lebwohl

http://www.w3.org/2001/XMLSchema#string

Newman Yeilding

http://www.w3.org/2001/XMLSchema#string

Richard G Langley

http://www.w3.org/2001/XMLSchema#string

Yuhua Wang

http://www.w3.org/2001/XMLSchema#string

P304

580-592

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA062382

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

356

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6518261

http://www.w3.org/2001/XMLSchema#string

P698

17287478

http://www.w3.org/2001/XMLSchema#string

P921